THE GIRAFFE Study: Genomic Risk Markers for Atrial Fibrillation Following Extended Cardiac Rhythm Monitoring
Conditions
- Patients With Symptoms of Cardiac Arrhythmia at Risk for Atrial Fibrillation
Sponsor
Scripps Translational Science Institute
Collaborators